Valuation: ConvaTec Group Plc

Market Cap 6.21B 5.52B 5.11B 4.65B 8.78B 589B 8.92B 61.45B 24.1B 307B 23.29B 22.79B 980B P/E 2026 *
24.6x
P/E 2027 * 16.9x
Enterprise Value 7.61B 6.76B 6.27B 5.7B 10.76B 722B 10.93B 75.34B 29.54B 377B 28.55B 27.94B 1,201B EV / Sales 2026 *
2.98x
EV / Sales 2027 * 2.72x
Free-Float
95.08%
Yield 2026 *
2.51%
Yield 2027 * 2.86%
1 day+0.51%
1 week+8.18%
Current month+9.68%
1 month+10.08%
3 months+11.53%
6 months+0.59%
Current year-2.14%
1 week 221
Extreme 221
239.6
1 month 209.2
Extreme 209.2
239.6
Current year 193
Extreme 193
259.3
1 year 193
Extreme 193
259.3
3 years 193
Extreme 193
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/10/26 Buy

Director

24,400 0.0013%
26/5/26 Buy

Chief Executive Officer

50,000 0.0026%
26/5/26 Buy

Chief Financial Officer

24,993 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%+8.18%-1.90%+17.82% 6.21B
+0.20%+5.31%-17.82%+13.79% 181B
-0.73%+7.09%-0.31%+32.06% 116B
+0.49%+6.25%-20.20%+11.58% 113B
+3.83%+5.50%-44.18%-6.77% 79.83B
-0.14%+5.27%+6.74%+82.45% 65.06B
+2.79%+2.37%+15.93%+68.64% 54.35B
-1.04%+4.35%+3.50%-26.18% 52.23B
+2.41%+8.18%-12.08%+30.45% 44.15B
-1.90%+2.29%+29.72%+8.98% 32.47B
Average +0.72%+5.58%-4.06%+23.28% 74.48B
Weighted average by Cap. +0.62%+5.61%-9.63%+22.10%

Financials

2026 *2027 *
Net sales 2.55B 2.27B 2.1B 1.91B 3.61B 242B 3.67B 25.29B 9.92B 126B 9.58B 9.38B 403B 2.73B 2.43B 2.25B 2.05B 3.86B 259B 3.93B 27.06B 10.61B 135B 10.25B 10.04B 431B
Net income 250M 222M 206M 187M 353M 23.7B 359M 2.47B 970M 12.37B 937M 917M 39.43B 364M 324M 300M 273M 515M 34.57B 523M 3.61B 1.41B 18.04B 1.37B 1.34B 57.51B
Net Debt 1.4B 1.25B 1.16B 1.05B 1.98B 133B 2.02B 13.89B 5.44B 69.45B 5.26B 5.15B 221B 1.22B 1.09B 1.01B 917M 1.73B 116B 1.76B 12.12B 4.75B 60.6B 4.59B 4.49B 193B
Projected Income Statement - Annual - ConvaTec Group Plc
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
16/10/26 GBX 238.00 +0.51% 7,261,498
15/10/26 GBX 236.80 +0.94% 24,281,065
14/10/26 GBX 234.60 +1.65% 44,889,089
13/10/26 GBX 230.80 +0.09% 11,817,903
12/10/26 GBX 230.60 +4.82% 6,611,650
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - ConvaTec Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.175USD
Average target price
4.016USD
Spread / Average Target
+26.50%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ConvaTec Group Plc
  1. Stock Market
  2. Stocks
  3. CTEC Stock